Advocacy Committee

The NASPAG advocacy committee advocates for the reproductive well-being of children and adolescents and the provision of unrestricted, unbiased and evidence based practice of PAG.

We collaborate extensively with other organizations, the Journal of Pediatric and Adolescent Gynecology, committees within NASPAG (social media, newsletter, education) and the NASPAG board of directors to develop, share and endorse projects aligned with our shared mission. We are frequently asked to support advocacy statements in a time sensitive fashion, so participation in the advocacy committee does require email attentiveness and desire to expand writing repertoire. It is a lively committee devoted to optimizing patient care and championing our patients and colleagues.

To contact the Advocacy Committee please email [email protected]

2022-2023 Advocacy Committee

*Co-Chair* *Megan Harrison, MD* Children's Hospital of Eastern Ontario Ottawa, ON		*Co-Chair* Mary Romano, MD, MPH Vanderbilt University Medical Center Nashville, TN
VP of Communications Megan Sumida, MD Kaiser Permanente Southern California Los Angeles, CA		*Elizabeth Alderman, MD* The Children’s Hospital at Montefiore Bronx, NY
*Shelby Davies, MD* Children's Hospital of Philadelphia Philadelphia, PA		*Kim Hoover, M.D.* University of Alabama Birmingham, AL
*Olga Kciuk,* MD University of Toronto Toronto, ON		*Andrew Lupo, M.D.* Children's Mercy Hospital Kansas City, MO
*Kate McCracken, MD* Nationwide Children's Hospital Columbus, OH		*Megan McCracken, MD* Stanford University Stanford, CA
*Seema Menon, MD* Medical College of Wisconsin Milwaukee, WI		*Diana Robillard, MD* Baystate Wing Hospital Springfield, MA
*Lauryn Roth, MD* Cincinnati Children's Hospital Medical Center Cincinnati, OH		*Kathryn Stambough, MD* Arkansas Children's Hospital Little Rock, AR
Whitney Wellenstein, MD Children's Hospital of the King's Daughter Norfolk, VA		Noor Zwayne, MD University of Texas - Dell Medical School Austin, TX

Quick Links

Latest News

NASPAG Statement to FDA on Over the Counter OCPs
NASPAG supports the availability of oral progesterone-only contraceptive pills to adolescents without a prescription. Read our Statement to the FDA

Media as a Megaphone: Influencing Adolescent Health or Trying To!
The recording from the October 18, 2022 discussion regarding Adolescent Health and the Media Presented by Hina Talib, MD, Adolescent Medicine Specialist, Atria Institute is now available! WATCH NOW

NASPAG Fellows Bootcamp
The Fall Fellows Bootcamp took place live remotely from September 27-29, and on October 3. All sessions were recorded for those who were unable to attend live.
Register to access the terrific programming FELLOWS BOOTCAMP REGISTRATION

NASPAG Eliminating Period Poverty Statement
NASPAG Advocacy Committee’s call to action to end period poverty

NASPAG Gender Affirming Care Statement
NASPAG Advocacy Committee Statement opposing legislation prohibiting evidence-based practice
NASPAG Gender Affirming Care Statement

NEW POSITION STATEMENT
COVID-19 Vaccines and Gynecologic Concerns
in Adolescent and Young Adults

With COVID-19 vaccine eligibility expanding into the adolescent age group, many teens, families and health care providers have thoughtful questions about the vaccine that are particular to this stage of development. Importantly, parents who accepted and even received the vaccine for themselves, have taken pause when approaching the vaccine for adolescents in their care citing specific concerns related to vaccine interactions with puberty, menstrual cycles, birth control and fertility. NASPAG COVID-19 Statement

NASPAG Gender Affirming Care for Minors Statement
NASPAG supports access to gender care for minors. Signs onto statement alongside other medical organizations opposing legislative efforts to resist access.
NASPAG Gender Affirming Care for Minors Statement